120 related articles for article (PubMed ID: 379334)
1. Potential radiosensitizing agents. Dinitroimidazoles.
Agrawal KC; Bears KB; Sehgal RK; Brown JN; Rist PE; Rupp WD
J Med Chem; 1979 May; 22(5):583-6. PubMed ID: 379334
[TBL] [Abstract][Full Text] [Related]
2. Potential radiosensitizing agents. 2. Synthesis and biological activity of derivatives of dinitroimidazole with oxiranes.
Sehgal RK; Webb MW; Agrawal KC
J Med Chem; 1981 May; 24(5):601-4. PubMed ID: 7241517
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
Ahmed I; Stratford IJ; Jenkins TC
Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
[TBL] [Abstract][Full Text] [Related]
4. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
[TBL] [Abstract][Full Text] [Related]
5. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS
J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345
[TBL] [Abstract][Full Text] [Related]
6. Potential Radiosensitizing Agents III: 2-Nitro-4-acetylimidazole analogs.
Sehgal RK; Agrawal KC
J Pharm Sci; 1982 Nov; 71(11):1203-6. PubMed ID: 7175708
[TBL] [Abstract][Full Text] [Related]
7. Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.
Sakaguchi M; Webb MW; Agrawal KC
J Med Chem; 1982 Nov; 25(11):1339-42. PubMed ID: 6890579
[TBL] [Abstract][Full Text] [Related]
8. Potential radiosensitizing agents. 6. 2-Nitroimidazole nucleosides: arabinofuranosyl and hexopyranosyl analogues.
Sakaguchi M; Larroquette CA; Agrawal KC
J Med Chem; 1983 Jan; 26(1):20-4. PubMed ID: 6827525
[TBL] [Abstract][Full Text] [Related]
9. Dual-function radiosensitizers. Alpha-[[(2-bromoethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol and related compounds: preparation via an aziridine equivalent.
Suto MJ; Stier MA; Werbel LM
J Med Chem; 1991 Mar; 34(3):1207-9. PubMed ID: 2002462
[TBL] [Abstract][Full Text] [Related]
10. Nitroimidazoles, XIV: Synthesis of 4-nitroimidazoles with 1-substituents containing acid, ester or phenol functions, and radiosensitizing efficiency of some of these compounds.
Suwinski J; Szczepankiewicz W; Widel M
Arch Pharm (Weinheim); 1992 Jun; 325(6):317-24. PubMed ID: 1444756
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ
J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716
[TBL] [Abstract][Full Text] [Related]
12. Potential radiosensitizing agents. 5. 2-Substituted benzimidazole derivatives.
Gupta RP; Larroquette CA; Agrawal KC
J Med Chem; 1982 Nov; 25(11):1342-6. PubMed ID: 7143372
[TBL] [Abstract][Full Text] [Related]
13. A comparative study on the radiosensitizing effects and cytotoxic properties of misonidazole and 2,4-dinitroimidazole-1-ethanol in HeLa S3 cells.
Murayama C; Hori H; Inayama S; Mori T
Gan; 1982 Aug; 73(4):588-91. PubMed ID: 7152197
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
[TBL] [Abstract][Full Text] [Related]
15. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
Zhou L; Nishimoto S
Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic radiosensitizers: prospects for effective compounds with fewer toxic side-effects.
Rupp WD; Mroczkowski Z; Agrawal KC
Br J Cancer Suppl; 1978 Jun; 3():60-3. PubMed ID: 98175
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents].
Adams DR; Martul R; Alvarez MV; López Zumel MC; Espada M
Acta Cient Venez; 1991; 42(5):257-65. PubMed ID: 1843567
[TBL] [Abstract][Full Text] [Related]
18. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
Papadopoulou MV; Rosenzweig HS; Bloomer WD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
[TBL] [Abstract][Full Text] [Related]
20. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin.
Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
